-
Aurigene, Curis To Conduct Phase 2 Trial On Cancer Drug 13 September 2017
Aurigene, Curis To Conduct Phase 2 Trial On Cancer Drug:- A wholly owned subsidiary of Dr Reddy’s Laboratories, the Aurigene Discovery Technologies Limited has unveiled its plans to initiate a Phase 2 trial of CA-170, a potential drug to treat...
Keywords: Aurigene, CA-170, Phase 2 Trial On Cancer Drug, Curis
Read More